Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production

View through CrossRef
Missense mutations in the amyloid precursor protein (APP) and presenilin-1 (PSEN1) cause early-onset familial Alzheimer’s disease (FAD) and alter proteolytic production of secreted 38-to-43-residue amyloid β-peptides (Aβ) by the PSEN1-containing γ-secretase complex, ostensibly supporting the amyloid hypothesis of pathogenesis. However, proteolysis of APP substrate by γ-secretase is processive, involving initial endoproteolysis to produce long Aβ peptides of 48 or 49 residues followed by carboxypeptidase trimming in mostly tripeptide increments. We recently reported evidence that FAD mutations in APP and PSEN1 cause deficiencies in early steps in processive proteolysis of APP substrate C99 and that this results from stalled γ-secretase enzyme-substrate and/or enzyme-intermediate complexes. These stalled complexes triggered synaptic degeneration in a Caenorhabditis elegans model of FAD independently of Aβ production. Here, we conducted full quantitative analysis of all proteolytic events on APP substrate by γ-secretase with six additional PSEN1 FAD mutations and found that all six are deficient in multiple processing steps. However, only one of these (F386S) was deficient in certain trimming steps but not in endoproteolysis. Fluorescence lifetime imaging microscopy in intact cells revealed that all six PSEN1 FAD mutations lead to stalled γ-secretase enzyme-substrate/intermediate complexes. The F386S mutation, however, does so only in Aβ-rich regions of the cells, not in C99-rich regions, consistent with the deficiencies of this mutant enzyme only in trimming of Aβ intermediates. These findings provide further evidence that FAD mutations lead to stalled and stabilized γ-secretase enzyme-substrate and/or enzyme-intermediate complexes and are consistent with the stalled process rather than the products of γ-secretase proteolysis as the pathogenic trigger.
Title: Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Description:
Missense mutations in the amyloid precursor protein (APP) and presenilin-1 (PSEN1) cause early-onset familial Alzheimer’s disease (FAD) and alter proteolytic production of secreted 38-to-43-residue amyloid β-peptides (Aβ) by the PSEN1-containing γ-secretase complex, ostensibly supporting the amyloid hypothesis of pathogenesis.
However, proteolysis of APP substrate by γ-secretase is processive, involving initial endoproteolysis to produce long Aβ peptides of 48 or 49 residues followed by carboxypeptidase trimming in mostly tripeptide increments.
We recently reported evidence that FAD mutations in APP and PSEN1 cause deficiencies in early steps in processive proteolysis of APP substrate C99 and that this results from stalled γ-secretase enzyme-substrate and/or enzyme-intermediate complexes.
These stalled complexes triggered synaptic degeneration in a Caenorhabditis elegans model of FAD independently of Aβ production.
Here, we conducted full quantitative analysis of all proteolytic events on APP substrate by γ-secretase with six additional PSEN1 FAD mutations and found that all six are deficient in multiple processing steps.
However, only one of these (F386S) was deficient in certain trimming steps but not in endoproteolysis.
Fluorescence lifetime imaging microscopy in intact cells revealed that all six PSEN1 FAD mutations lead to stalled γ-secretase enzyme-substrate/intermediate complexes.
The F386S mutation, however, does so only in Aβ-rich regions of the cells, not in C99-rich regions, consistent with the deficiencies of this mutant enzyme only in trimming of Aβ intermediates.
These findings provide further evidence that FAD mutations lead to stalled and stabilized γ-secretase enzyme-substrate and/or enzyme-intermediate complexes and are consistent with the stalled process rather than the products of γ-secretase proteolysis as the pathogenic trigger.

Related Results

Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Abstract Missense mutations in the amyloid precursor protein (APP) and presenilin-1 (PSEN1) cause early-onset familial Alzheimer’s disease (FAD) and alter proteolyt...
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Abstract Missense mutations in the amyloid precursor protein (APP) and presenilin-1 (PSEN1) cause early-onset familial Alzheimer’s disease (FAD) ...
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
Abstract Missense mutations in the amyloid precursor protein (APP) and presenilin-1 (PSEN1) cause early-onset familial Alzheimer’s disease (FAD) and alter proteolyt...
Mechanism of Tripeptide Trimming by γ-Secretase
Mechanism of Tripeptide Trimming by γ-Secretase
Abstract The membrane-embedded γ-secretase complex processively cleaves within the transmembrane domain of amyloid precursor protein (APP) to pro...
γ-secretase facilitates retromer-mediated retrograde transport
γ-secretase facilitates retromer-mediated retrograde transport
Abstract The retromer complex mediates retrograde transport of protein cargos from endosomes to the trans-Golgi network (TGN). γ-secretase is a multisubunit proteas...
Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers
Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers
Abstract The relationship between cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease and neurodegenerative effects is not fully understood. This study inves...
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
AbstractUnder the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosph...
Potensi Ashwagandha (Withania somnifera (L.) Dunal) sebagai Pengobatan Alzheimer
Potensi Ashwagandha (Withania somnifera (L.) Dunal) sebagai Pengobatan Alzheimer
Ashwagandha (Withania somnifera (L.) Dunal) adalah tanaman herbal yang telah lama digunakan dalam pengobatan tradisional Ayurveda. Penelitian ilmiah terbaru mengungkap potensi neur...

Back to Top